Sernova Corp. (PSH.F)
- Previous Close
0.2900 - Open
0.2804 - Bid 0.2886 x 1000000
- Ask 0.3008 x 1000000
- Day's Range
0.2598 - 0.3028 - 52 Week Range
0.2588 - 0.7795 - Volume
33,500 - Avg. Volume
5,982 - Market Cap (intraday)
91.872M - Beta (5Y Monthly) 1.48
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0900 - Earnings Date Jun 12, 2024 - Jun 16, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.
www.sernova.comRecent News: PSH.F
Performance Overview: PSH.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PSH.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PSH.F
Valuation Measures
Market Cap
91.11M
Enterprise Value
80.93M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
35.11
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-2.01
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-79.96%
Return on Equity (ttm)
-183.58%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-40.73M
Diluted EPS (ttm)
-0.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
15.55M
Total Debt/Equity (mrq)
16.55%
Levered Free Cash Flow (ttm)
-14.33M
Company Insights: PSH.F
PSH.F does not have Company Insights